Made in the USA                     |                      Sign up for 15% discount                     |                     Free shipping on orders over $150                    
There are 0 item(s) in your cart
Subtotal: $0.00

Retatrutide

Compound Retatrutide
Strength 10mg, 20mg, 30mg, 40mg
Size_value 10, 20, 30, 40
Size_unit mg
Vial_count 1
Purity_claim ≥99%
Format lyophilized vial

 

10mg

Quantity Discount Price
5 – 8 5% $94.05
9 + 10% $89.10

Price range: $149.00 through $399.00

Quantity:
Buy Now
SKU N/A Categories ,

Description

Retatrutide (LY3437943) is a novel synthetic peptide and the first “triple hormone receptor agonist” to enter advanced research phases. It builds upon the mechanisms of earlier GLP-1 (Semaglutide) and dual GLP-1/GIP (Tirzepatide) agonists by adding a third target: Glucagon.

Researchers categorize Retatrutide as a “GGG” agonist because it simultaneously activates the receptors for GLP-1 (Glucagon-like Peptide-1), GIP (Glucose-dependent Insulinotropic Polypeptide), and GCGR (Glucagon Receptor). This unique triple-action mechanism is investigated for its potential to produce unprecedented efficacy in metabolic regulation. While GLP-1 and GIP work synergistically to improve insulin secretion and suppress appetite, the addition of Glucagon agonism is hypothesized to increase energy expenditure (thermogenesis) and enhance lipid metabolism in the liver, theoretically accelerating the reduction of adipose tissue beyond what is possible with dual agonists.

Key Research Applications

  • Maximal Efficacy Weight Regulation: Retatrutide is currently the “ceiling” of weight loss research. Phase 2 clinical data (published in The New England Journal of Medicine) observed mean body weight reductions of up to 24.2% in test subjects over 48 weeks—outperforming all previous generations of incretin mimetics.

  • Hepatic Health (Fatty Liver): Due to the specific inclusion of the Glucagon receptor (which promotes hepatic lipid clearance), Retatrutide is a primary subject of investigation for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease). Research indicates it may rapidly mobilize liver fat, improving hepatic markers faster than GLP-1 mono-therapies.

  • Energy Expenditure: The “Glucagon component” is researched for its ability to increase resting metabolic rate. Unlike Tirzepatide which primarily lowers caloric intake, Retatrutide is investigated for both lowering intake and increasing output.

⚠️ FOR RESEARCH PURPOSES ONLY This product is intended for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic use. Handle with care and adhere to all laboratory safety protocols.

Additional information

Compound

Retatrutide

Strength

10mg, 20mg, 30mg, 40mg

Size_value

10, 20, 30, 40

Size_unit

mg

Vial_count

1

Purity_claim

≥99%

Format

lyophilized vial

Reviews

Write a Review

Be the first to review “Retatrutide”

Your email address will not be published. Required fields are marked *

Reviews

There are no reviews yet.